Total Payments
$2.7M
2024 Payments
$589,869
Companies
38
Transactions
3,556
Payment Breakdown by Category
Other$2.0M (75.7%)
Travel$364,287 (13.6%)
Consulting$214,746 (8.0%)
Food & Beverage$70,684 (2.6%)
Education$187.10 (0.0%)
Gifts$40.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.0M | 756 | 73.4% |
| Travel and Lodging | $364,287 | 1,307 | 13.6% |
| Consulting Fee | $214,746 | 76 | 8.0% |
| Food and Beverage | $70,684 | 1,384 | 2.6% |
| Honoraria | $49,854 | 15 | 1.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $10,280 | 4 | 0.4% |
| Education | $187.10 | 13 | 0.0% |
| Gift | $40.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $761,268 | 1,067 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $588,183 | 631 | $0 (2024) |
| Alkermes, Inc. | $329,389 | 404 | $0 (2024) |
| ITI, Inc. | $205,860 | 191 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $180,171 | 177 | $0 (2024) |
| Axsome Therapeutics, Inc. | $133,074 | 152 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $100,083 | 213 | $0 (2022) |
| H. Lundbeck A S | $83,586 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $47,001 | 162 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $44,366 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $589,869 | 626 | Otsuka America Pharmaceutical, Inc. ($128,527) |
| 2023 | $459,709 | 528 | ITI, Inc. ($133,044) |
| 2022 | $283,165 | 338 | Neurocrine BioSciences, Inc. ($109,682) |
| 2021 | $242,838 | 335 | Otsuka America Pharmaceutical, Inc. ($83,768) |
| 2020 | $93,528 | 227 | Otsuka America Pharmaceutical, Inc. ($33,964) |
| 2019 | $347,546 | 527 | Otsuka America Pharmaceutical, Inc. ($120,428) |
| 2018 | $351,807 | 485 | Otsuka America Pharmaceutical, Inc. ($118,394) |
| 2017 | $302,099 | 490 | Alkermes, Inc. ($103,695) |
All Payment Transactions
3,556 individual payment records from CMS Open Payments — Page 1 of 143
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $33.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Travel and Lodging | In-kind items and services | $4,347.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,074.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Travel and Lodging | In-kind items and services | $344.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $61.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,750.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $761.95 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $524.47 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $164.32 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $153.87 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $136.25 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $61.55 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $53.28 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $45.80 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,312.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,548.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $98.56 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,620.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CNS | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Neuropsychiatry | ||||||
About Dr. Ilan Melnick, M.D
Dr. Ilan Melnick, M.D is a Psychiatry healthcare provider based in Coral Gables, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427048115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilan Melnick, M.D has received a total of $2.7M in payments from pharmaceutical and medical device companies, with $589,869 received in 2024. These payments were reported across 3,556 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.0M).
Ad
Practice Information
- Specialty Psychiatry
- Location Coral Gables, FL
- Active Since 10/25/2005
- Last Updated 01/04/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427048115
Products in Payments
- INGREZZA (Drug) $580,624
- REXULTI (Drug) $409,592
- ABILIFY MAINTENA (Drug) $392,966
- CAPLYTA (Drug) $250,226
- Aristada 441 mg (Drug) $182,814
- UZEDY (Drug) $142,837
- Auvelity (Drug) $132,949
- ARISTADA (Drug) $126,678
- LATUDA (Drug) $99,971
- Trintellix (Drug) $77,852
- Austedo XR (Drug) $31,416
- PERSERIS (Drug) $30,925
- ABILIFY ASIMTUFII (Drug) $22,610
- SECUADO (Drug) $19,974
- BRINTELLIX (Drug) $16,449
- BELSOMRA (Drug) $15,132
- LYBALVI (Drug) $14,056
- VRAYLAR (Drug) $11,487
- Dayvigo (Drug) $10,902
- Xelstrym (Drug) $9,409
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Coral Gables
Dr. Moraima Trujillo, M.d, M.D
Psychiatry — Payments: $205,113
Psychiatry $205,113
Manuela Georgescu, Md, MD
Psychiatry — Payments: $11,668
Psychiatry $11,668
Antonio Tauler, Md, MD
Psychiatry — Payments: $10,566
Psychiatry $10,566
Arthur Bregman, M.d, M.D
Psychiatry — Payments: $7,740
Psychiatry $7,740
Dr. Hugh Humphery, M.d, M.D
Psychiatry — Payments: $4,527
Psychiatry $4,527
Ana Castellanos, Md, Pa, MD, PA
Psychiatry — Payments: $3,370
Psychiatry $3,370